UHS

Business Context and Reporting Period

Company: Universal Health Services, Inc.
Filing Type: Form 10-Q (Quarterly Report)
Period Ended: September 30, 2003
Business Overview: The Company operates acute care hospitals, behavioral health care facilities, and international acute care hospitals (primarily in France). It also operates outpatient surgery and radiation centers.

Key Financial Metrics

Material Changes vs. Prior Period

• Revenue Growth: Net revenues increased 10% ($83 million) for the quarter and 11% ($271 million) for the nine-month period compared to 2002. Growth was driven by organic increases at existing facilities and revenues from acquisitions in France and the U.S.
• Profitability: Net income rose 18% for the quarter and 16% for the nine-month period. Operating margins improved slightly to 15.4% (quarter) and 16.3% (nine months), aided by a decrease in the provision for doubtful accounts and lower pharmacy costs due to outsourcing.
• Segment Performance:
  • Acute Care: Same-facility revenues increased 7% (quarter) and 9% (nine months). Operating margins improved to 17.0% and 18.0% respectively.
  • Behavioral Health: Same-facility revenues increased 4%. Operating margins improved significantly to 22.4% and 22.8% respectively.
  • International/Other: Margins decreased due to lower margins at newly acquired French facilities and GAAP reclassifications.
• Capital Expenditures: The Company spent $167 million on property and equipment for the nine months ended September 30, 2003, compared to $163 million in the prior year period.

Guidance, Outlook, and Risks

• Acquisitions: The Company signed agreements to acquire a 90% interest in Pendleton Memorial Methodist Hospital (New Orleans) and three acute care hospitals in California for a combined price of approximately $228 million. Closing is expected in Q4 2003, subject to regulatory and bankruptcy approvals.
• Capital Expenditure Outlook: Estimated full-year 2003 capital expenditures are projected to be between $200 million and $225 million.
• Dividend: The Board is planning to declare a quarterly cash dividend of $0.08 per share, payable in Q4 2003.
• Reimbursement Risks: Significant revenue reliance on Medicare (approx. 41%) and Medicaid. Risks include potential reductions in reimbursement rates, changes to the Prospective Payment System (PPS), and the expiration of transitional corridor payments.
• Insurance Contingencies:
  • Self-Insurance: Due to market conditions, subsidiaries are self-insured for malpractice up to $25 million per occurrence. Total accrual for professional and general liability claims was $176.1 million as of September 30, 2003.
  • PHICO Liquidation: The Company recorded a $40 million charge in 2001 related to the liquidation of insurer PHICO. While reserves are established, ultimate liability could differ materially.
• Regulatory: Compliance with HIPAA privacy and security standards is ongoing. New CMS rules regarding outlier payments and transfer definitions may impact future revenues.

Investor Verification Checklist

• Acquisition Closing: Verify the completion status and regulatory approval of the $228 million California hospital acquisition and the New Orleans facility purchase.
• Insurance Reserves: Monitor the adequacy of the $176.1 million liability reserve, particularly regarding PHICO-related claims and self-insured malpractice exposure.
• Reimbursement Rates: Track changes in Medicare and Medicaid reimbursement policies, specifically regarding the expiration of transitional corridor payments and new outlier payment formulas.
• Capital Spending: Confirm actual capital expenditures against the $200-$225 million full-year guidance.
• French Operations: Assess the integration and margin performance of the newly acquired French hospitals, which currently drag down the "Other" segment margins.